Document is current
Any future updates will be listed below
-
Authors
Vander Elst, Niels https://orcid.org/0000-0001-6289-7288
Bellemans, Julie https://orcid.org/0000-0001-8803-7972
Lavigne, Rob https://orcid.org/0000-0001-7377-1314
Briers, Yves https://orcid.org/0000-0001-7723-1040
Meyer, Evelyne https://orcid.org/0000-0002-7066-8255
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (1.S.236.20N)
- License Information
-
More Information
Article History
Received: 29 August 2023
Revised: 7 December 2023
Accepted: 18 December 2023
First Online: 10 January 2024
Declarations
:
: All applicable international, national, and institutional guidelines for the care and use of animals were followed. The experimental procedures on mice were executed at the Faculty of Veterinary Medicine of Ghent University (Merelbeke, Belgium) and with approval of the ethics committee (approval number: 2021/096).
: The VersaTile engineered endolysin NC5 is the subject of an issued and pending patent, submitted at the European Patent Office with application number EP 23164960.9. This applies to authors NV, RL, YB, and EM.
